Skip to main content

Table 1 Subtypes of lymphomas (n = 6,382)

From: Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution

   Age (year) Sex Site
Subtype No. Median Range Male Female M:F Nodal Extranodal N/E
DLBCL 2288 55 3-93 1359 929 1.5 1027 1261 0.81
ENKTCL 949 41 1-82 668 281 2.4 32 917 0.03
MALT 350 56 16-86 183 167 1.1 20 330 0.06
FL 327 54 23-83 213 114 1.9 292 35 8.34
LBL 301 19 1-71 211 90 2.3 253 48 5.27
CLL/SLL 256 60 22-88 180 76 2.4 228 28 8.14
PTCL, NOS 221 55 12-90 148 73 2 152 69 2.2
ALCL 196 27.5 4-71 118 78 1.5 151 45 3.36
AITL 185 61 20-86 124 61 2 185 0 -
MCL 175 61 20-79 132 43 3.1 126 49 2.57
Burkitt 106 15.5 2-69 78 28 2.8 49 57 0.86
SPTCL 54 33 4-68 25 29 0.9 0 54 0
LPL 44 61 30-82 25 19 1.3 34 10 3.4
PCCD30LD 37 37 2-78 18 19 0.9 0 37 -
SMZBCL 20 61.5 15-76 10 10 1 20 0 -
HSTCL 14 25 11-46 9 5 1.8 5 9 0.56
MF/SS 14 52.5 31-80 8 6 1.3 0 14 -
ETCL 7 29 17-42 5 2 2.5 0 7 -
NMZBCL 5 64 52-80 3 2 1.5 5 0 -
MC-CHL 606 31 3-89 433 173 2.5 597 9 66.3
NS-CHL 145 29 3-76 75 70 1.1 139 6 23.2
LR-CHL 35 30 4-64 29 6 4.8 35 0 -
LD-CHL 12 53 19-82 6 6 1 12 0 -
NLPHL 35 36 8-74 25 10 2.5 34 1 34
Total 6382 50 1-93 4085 2297 1.8 3396 2986 1.1
  1. DLBCL, diffuse large B-cell lymphoma; ENKTCL, extranodal NK/T-cell lymphoma, nasal type; MALT, extranodal marginal zone lymphoma of mucosa associated lymphoid tissue; FL, follicular lymphoma; LBL, lymphoblastic leukemia/lymphoma; CLL/SLL, chronic lymphocytic leukemia/small lymphocytic lymphoma; PTCL, NOS, peripheral T-cell lymphoma, not otherwise specified; ALCL, anaplastic large cell lymphoma; AITL, angioimmunoblastic T-cell lymphoma; MCL, mantle cell lymphoma; Burkitt, Burkitt lymphoma; SPTCL, subcutaneous panniculitis-like T-cell lymphoma; LPL, lymphoplasmacytic lymphoma; PCCD30LD, primary cutaneous CD30 positive lymphoproliferative disorders; SMZBCL, splenic marginal zone B-cell lymphoma; HSTCL, hepatosplenic T-cell lymphoma; MF/SS, mycosis fungoides/Sezary syndrome; ETCL, enteropathy-associated T-cell lymphoma; NMZBCL, nodal marginal zone B-cell lymphoma; MC-CHL, mixed cellularity classical Hodgkin lymphoma; NS-CHL, nodular sclerosis classical Hodgkin lymphoma; LR-CHL, lymphocyte-rich classical Hodgkin lymphoma; LD-CHL, lymphocyte-depleted classical Hodgkin lymphoma; NLPHL, nodular lymphocyte predominant Hodgkin lymphoma.